| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1411 | 2018 |
| Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes SJ Creely, PG McTernan, CM Kusminski, M Fisher, NF Da Silva, ... American Journal of Physiology-Endocrinology and Metabolism 292 (3), E740-E747, 2007 | 1231 | 2007 |
| Does central obesity reflect “Cushing's disease of the omentum”? IJ Bujalska, S Kumar, PM Stewart The Lancet 349 (9060), 1210-1213, 1997 | 1019 | 1997 |
| LMNA, encoding lamin A/C, is mutated in partial lipodystrophy S Shackleton, DJ Lloyd, SNJ Jackson, R Evans, MF Niermeijer, BM Singh, ... Nature genetics 24 (2), 153-156, 2000 | 831 | 2000 |
| Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease AR Baker, NF Da Silva, DW Quinn, AL Harte, D Pagano, RS Bonser, ... Cardiovascular diabetology 5, 1-7, 2006 | 794 | 2006 |
| Resistin, central obesity, and type 2 diabetes CL McTernan, PG McTernan, AL Harte, PL Levick, AH Barnett, S Kumar The Lancet 359 (9300), 46-47, 2002 | 699 | 2002 |
| Cortisol metabolism in human obesity: impaired cortisone→ cortisol conversion in subjects with central adiposity PM Stewart, A Boulton, S Kumar, PMS Clark, CHL Shackleton The Journal of Clinical Endocrinology & Metabolism 84 (3), 1022-1027, 1999 | 572 | 1999 |
| Increased resistin gene and protein expression in human abdominal adipose tissue PG McTernan, CL McTernan, R Chetty, K Jenner, FM Fisher, MN Lauer, ... The journal of clinical endocrinology & metabolism 87 (5), 2407-2410, 2002 | 567 | 2002 |
| The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population‐based study S Kumar, HA Ashe, LN Parnell, DJS Fernando, C Tsigos, RJ Young, ... Diabetic medicine 11 (5), 480-484, 1994 | 566 | 1994 |
| Elevated endotoxin levels in non-alcoholic fatty liver disease AL Harte, NF da Silva, SJ Creely, KC McGee, T Billyard, ... Journal of inflammation 7, 1-10, 2010 | 564 | 2010 |
| Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins CA Abbott, MI Mackness, S Kumar, AJ Boulton, PN Durrington Arteriosclerosis, thrombosis, and vascular biology 15 (11), 1812-1818, 1995 | 543 | 1995 |
| Role of resistin in obesity, insulin resistance and Type II diabetes CM Kusminski, PG Mcternan, S Kumar Clinical science 109 (3), 243-256, 2005 | 439 | 2005 |
| Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration S Kumar, DJS Fernando, A Veves, EA Knowles, MJ Young, AJM Boulton Diabetes research and clinical practice 13 (1-2), 63-67, 1991 | 411 | 1991 |
| Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human … PG McTernan, FFM Fisher, G Valsamakis, R Chetty, A Harte, ... The Journal of Clinical Endocrinology & Metabolism 88 (12), 6098-6106, 2003 | 395 | 2003 |
| Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase IJ Bujalska, S Kumar, M Hewison, PM Stewart Endocrinology 140 (7), 3188-3196, 1999 | 381 | 1999 |
| Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin MK Piya, PG McTernan, S Kumar J Endocrinol 216 (1), T1-T15, 2013 | 373 | 2013 |
| Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients S Kumar, AJM Boulton, H Beck-Nielsen, F Berthezene, M Muggeo, ... Diabetologia 39, 701-709, 1996 | 341 | 1996 |
| Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males M Fisher, ME Trujillo, W Hanif, AH Barnett, PG McTernan, PE Scherer, ... Diabetologia 48, 1084-1087, 2005 | 340 | 2005 |
| How strong is the association between abdominal obesity and the incidence of type 2 diabetes? N Freemantle, J Holmes, A Hockey, S Kumar International journal of clinical practice 62 (9), 1391-1396, 2008 | 327 | 2008 |
| Type 2 diabetes and cardiovascular risk in the UK south Asian community AH Barnett, AN Dixon, S Bellary, MW Hanif, JP O’Hare, NT Raymond, ... Diabetologia 49, 2234-2246, 2006 | 305 | 2006 |
Nasser Al-DaghriProfessor of Biochemistry, King Saud University在 ksu.edu.sa 的电子邮件经过验证
